Ignite Creation Date:
2024-05-06 @ 2:05 PM
Last Modification Date:
2024-10-26 @ 1:24 PM
Study NCT ID:
NCT04201782
Status:
TERMINATED
Last Update Posted:
2024-01-26
First Post:
2019-12-13
Brief Title:
Long-term Follow-up of HIV Subjects Exposed to SB-728-T or SB-728mR-T
Sponsor:
Organization:
Sangamo Therapeutics
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
NONE_RETAINED
Bio Spec Description:
1 Clinical condition assessment
2 Chemistry which includes bilirubin alanine aminotransferase ALT aspartate aminotransferase AST alkaline phosphatase ALP sodium potassium chloride bicarbonate urea nitrogen creatinine total protein albumin calcium and phosphorous
3 CBC which includes hemoglobin hematocrit platelet count red cell count and white cell count with differential count
4 CD4 T-cell count
5 HIV-1 RNA
6 HIV proviral DNA
7 Pentamer
8 Ad5 and SB-728-T immunogenicity
9 Research blood
Enrollment Count:
38
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 61054 |
Who Masked List: